Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 7 of 7 clinical reviews.
Is compounding ezetimibe (Zetia) legal? Full regulatory breakdown covering FDA approval history, compounding restrictions under 503A/503B, the current label, and safety data from IMPROVE-IT.
Read clinical reviewA detailed review of ezetimibe (Zetia) adverse event reports in the FDA FAERS database, including musculoskeletal, hepatobiliary, and hypersensitivity signals, with clinical context from IMPROVE-IT and current prescribing guidance.
Read clinical reviewA complete regulatory timeline of ezetimibe (Zetia) from its 2002 FDA approval through IMPROVE-IT outcomes data, generic entry, and current labeling.
Read clinical reviewComplete regulatory overview of ezetimibe (Zetia) worldwide, covering FDA approval history, EMA authorization, label updates, IMPROVE-IT trial impact, generic availability, and ongoing post-market surveillance.
Read clinical reviewA clinical review of ezetimibe's regulatory timeline, patent litigation, ENHANCE controversy, IMPROVE-IT vindication, and the legal battles that shaped generic Zetia access.
Read clinical reviewA detailed comparison of how the FDA and EMA have regulated ezetimibe (Zetia/Ezetrol), from initial approval through post-market surveillance, label updates, and the IMPROVE-IT outcomes data.
Read clinical reviewA clinical review of ezetimibe (Zetia) regulatory history, FDA approval timeline, current label details, post-market safety surveillance, and next-generation lipid-lowering pipeline candidates.
Read clinical review